Is renal denervation an alternative or a complement to aldosterone antagonists in treatment of resistant hypertension?

Affiliations

¹ Assistance-Publique Hôpitaux de Paris, Department of Pharmacology, Hôpital Européen Georges Pompidou, Paris-Descartes University, INSERM UMRS970, Paris, France.

Editorial

Idir Hamdidouche et al. J Hypertens. 2017 May.

. 2017 May;35(5):955-957.

doi: 10.1097/HJH.0000000000001320.

¹ Assistance-Publique Hôpitaux de Paris, Department of Pharmacology, Hôpital Européen Georges Pompidou, Paris-Descartes University, INSERM UMRS970, Paris, France.

No abstract available

Comment on

Renal denervation in comparison with intensified pharmacotherapy in true resistant hypertension: 2-year outcomes of randomized PRAGUE-15 study.
Rosa J, Widimský P, Waldauf P, Zelinka T, Petrák O, Táborský M, Branny M, Toušek P, Čurila K, Lambert L, Bednář F, Holaj R, Štrauch B, Václavík J, Kociánová E, Nykl I, Jiravský O, Rappová G, Indra T, Krátká Z, Widimský J Jr. Rosa J, et al. J Hypertens. 2017 May;35(5):1093-1099. doi: 10.1097/HJH.0000000000001257. J Hypertens. 2017. PMID: 28118281 Clinical Trial.